BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.56
-0.22 (-2.51%)
Sep 23, 2026, 4:00 PM EDT - Market closed
BioCryst Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Downgrades $13 → $11 | Hold | Downgrades | $13 → $11 | +28.50% | Sep 10, 2026 |
| Needham | Needham | Buy Maintains $16 | Buy | Maintains | $16 | +86.92% | Sep 8, 2026 |
Unknown Analyst Evercore ISI No rating | Evercore ISI | Buy Maintains $17 | Buy | Maintains | $17 | +98.60% | Aug 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $32 | Buy | Maintains | $32 | +273.83% | Aug 6, 2026 |
| Wedbush | Wedbush | Buy Maintains $20 | Buy | Maintains | $20 | +133.64% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $30 | Buy | Maintains | $30 | +250.47% | Aug 6, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +75.23% | Jul 15, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Initiates $12 | Hold | Initiates | $12 | +40.19% | Jul 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.